ozempic teeth: dentists warn of new glp-1 side effect Patients taking or other medications are being warned a complication not listed as a common effect, as see an increase in those taking the drug reporting cases Ozempic Teeth: Dentists Warn Of

Published studies consistently show GLP-1 receptor agonists slow gastric emptying and influence intestinal movement

10.1172/jci42497 72 LauJ.BlochP.SchfferL.PetterssonI.SpetzlerJ.KofoedJ.et al (2015)

A more comprehensive approach considers your genetic predispositions in peptide pathways, baseline metabolic markers, and clinical response potential

17 Recent advances in pharmacological treatments Sodium-glucose cotransporter-2 inhibitors SGLT-2 inhibitors (empagliflozin and dapagliflozin) are recommended in most people with type 2 diabetes and CKD, given the strong evidence that SGLT-2 inhibitors reduce CKD progression, heart failure and the risk of atherosclerotic CV disease in people with type 2 diabetes and CKD

They may need more help, yes